USPTO serial 79300833
LIAISON LYMEDETECT
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Oct 26, 2021
- Examiner
- MASON, JARED MICHAEL
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
This registration is in, or will soon enter, a USPTO maintenance window. Missing a Section 8 or Section 9 filing can cancel the registration.
Need help with LIAISON LYMEDETECT?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Get help with this Renewal, set up monitoring, or talk with CopyMark.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 001 | Diagnostic preparations for scientific or research use; diagnostic reagents and chemical reagents, for laboratory or research use, not for medicinal purposes; blood glucose control solutions used in diagnostic test kits, for laboratory or research use; diagnostic test kits consisting primarily of monoclonal antibodies, buffers, and reagents to monitor toxicity of drugs for laboratory use; scientific chemical products for diagnostic use in the nature of chemical test paper; chemical and reagent solutions being chemical reagents used in diagnostic test kits, not for medical purposes; diagnostic biomarker reagents for analytical, research and scientific use; assays and reagents for use in genetic research; chemically treated test strips, other than for medical purposes for testing the pH of liquids; chromatography chemicals for laboratory use; reagents for use in scientific apparatus for chemical or biological analysis for testing the presence of antigens in blood, human serum, plasma, urine, other biological fluids, and tissue; chemically treated non-medical test strips for detecting alcohol and drugs | ACTIVE | — |
| 005 | Diagnostic preparations for medical purposes; diagnostic substances for medical purposes; diagnostic reagents for use in diagnostic tests for medical purposes; chemical preparations for testing blood for medical purposes; chemical preparations for testing blood for veterinary purposes; in vitro diagnostic preparations for medical purposes; in vitro diagnostic preparations for veterinary purposes; chemicals reagents for testing DNA for medical purposes; nucleic acid sequences for medical and veterinary purposes; diagnostic reagents for use in diagnostic tests for veterinary purposes; reactants for medical diagnosis being diagnostic preparations for medical purposes; clinical medical diagnostic reagents; diagnostic biomarker reagents for medical purposes; diagnostic biomarker reagents for veterinary purposes; indicators for medical diagnosis being diagnostic preparations for medical purposes; diagnostic substances for medical use; diagnostic substances for veterinary use; medicated antiserums for diagnostic purposes for diagnosing skin conditions; chemical test reagents for medical purposes; chemical test reagents for veterinary purposes; reagents for microbiological analysis for medical purposes; reagents for microbiological analysis for veterinary purposes; reagents for use with analyzers for medical purposes; reagents for use with analyzers for veterinary purposes; diagnostic chemical reagents for medical use; diagnostic chemical reagents for veterinary use; medical diagnostic reagents and assays for testing of body fluids; diagnostic agents for pharmaceutical use; test strips for measuring blood glucose levels; medical diagnostic test strips for monitoring blood sugar levels; medical diagnostic kits comprising diagnostic reagents for extracting, testing and analyzing body fluids, nucleic acids, DNA, RNA; medical diagnostic kits comprising diagnostic reagents for extracting, isolating, testing and analyzing blood cells; test strips containing medical diagnostic reagents for measuring blood glucose levels | ACTIVE | — |
| 009 | Scientific apparatus and instruments for measuring relative DNA, RNA and protein and parts and fittings therefor; laboratory apparatus and instruments for conducting and evaluating diagnostic examinations for medical purposes, and parts and fittings therefor, namely, microscopes, microscope slides; diagnostic instruments for scientific purposes in the nature of diagnostic apparatus for testing food; diagnostic testing apparatus for scientific and research testing being diagnostic apparatus for testing food; computer systems comprising of computer hardware and downloadable computer software for collecting, storing, analysing and reporting biological information, and for sample tracking and managing projects, laboratory workflows and data, for use in the fields of scientific, diagnostic and clinical research and for clinical diagnostic purposes; downloadable software for use with electronic medical and diagnostic apparatus; downloadable software and downloadable software containing algorithms, in particular downloadable computer databases, for helping to make medical decisions or carry out research, for diagnostic and therapeutic applications; computer hardware for medical and diagnostic tasks; devices in the nature of computer hardware for generating images for detecting, quantifying and linking biological or chemical molecules; liquid analyzers; laboratory instruments, namely, genome sequencers being laboratory devices for detecting genetic sequences; specimen containers, namely, petri dishes | ACTIVE | — |
| 010 | Kits for medical diagnostic applications in the nature of medical test kits for diabetes monitoring for home use; apparatus for carrying out medical diagnoses, in particular fluorescence diagnostic apparatus and instruments used for the purpose of identifying infectious diseases and the severity thereof being medical diagnostic apparatus for detecting cancer; electromagnetic medical diagnostic imaging apparatus for medical use; electromagnetic medical diagnostic imaging apparatus for medical purposes containing fluorimeters used to register fluorescence signals and produce data; diagnostic lasers for medical purposes; medical and diagnostic devices, apparatus and/or equipment for molecular analysis being medical diagnostic apparatus for testing DNA and RNA samples; scanners for medical diagnosis, namely, x-ray CT scanners; blood spectrum analyzers for use in medical diagnosis; ultrasonic medical diagnostic apparatus; magnetic field generators for medical purposes, namely, magnetic resonance imaging apparatus for medical purposes; electromagnetic medical diagnostic imaging apparatus; optical instruments for medical diagnostics in the nature of optometric instruments for locating the optical center of ophthalmic lenses; containers for sample analysis, syringes and plungers being containers for medical waste; sampling vials of plastic or other materials being blood sampling tubes; preparation vials of plastic or other materials being blood sampling tubes; devices containing reagents for medical diagnostic test use, namely, capillary reagent tubes; test devices containing chemical reagents for in-vitro diagnostic medical testing being sample preparation device for medical diagnostic uses | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by DIASORIN S.P.A.
- Other trademarks owned by DIASORIN S.P.A.
- Other trademarks owned by DIASORIN S.P.A.
- Other trademarks in Class 001
- Other trademarks in Class 005
- Other trademarks in Class 009
- Other trademarks in Class 010
- Similar marks named LIAISON LYMEDETECT
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| May 9, 2022 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Apr 19, 2022 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Apr 19, 2022 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Jan 26, 2022 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Oct 26, 2021 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Aug 15, 2021 | GPNX | NOTIFICATION PROCESSED BY IB | — |
| Aug 10, 2021 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Aug 10, 2021 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Jul 28, 2021 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Jul 28, 2021 | OP2R | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB | — |
| Jul 21, 2021 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Jul 1, 2021 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Jun 22, 2021 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Jun 21, 2021 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jun 21, 2021 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jun 15, 2021 | CHAN | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | — |
| Jun 15, 2021 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Jun 15, 2021 | ECDR | TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS | — |
| Jun 15, 2021 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jun 15, 2021 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Jun 15, 2021 | COAR | TEAS CHANGE OF OWNER ADDRESS RECEIVED | — |
| Feb 14, 2021 | RFNT | REFUSAL PROCESSED BY IB | — |
| Jan 25, 2021 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Jan 25, 2021 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Jan 5, 2021 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Jan 4, 2021 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jan 1, 2021 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Dec 28, 2020 | DOCK | ASSIGNED TO EXAMINER | — |
| Dec 28, 2020 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Dec 24, 2020 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |